The HDL Particle Protection Study
NCT02125682
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
16
Enrollment
OTHER
Sponsor class
Conditions
Dyslipidemia in Patients With Diabetes Mellitus
Interventions
DRUG:
atovastatin 10 mg/day
DRUG:
Atorvastatin 80 mg/day
Sponsor
Hotel Dieu de France Hospital
Collaborators
[object Object]
[object Object]